
    
      There are two BRCA genes, BRCA1 and BRCA2, and they play a role in protecting cells from
      cancer. If one of these genes is mutated, cells may rapidly change and divide, which can lead
      to cancer. Pembrolizumab is a drug that works with the immune system to target the tumor
      (immunotherapy). The investigators want to know if adding pembrolizumab to standard of care
      Olaparib therpy will be able to reduce the size and amount of cancer cells with fewer side
      effects than standard treatment by targeting the tumor.This research study is designed to
      test the investigational use of pembrolizumab in breast cancer.
    
  